Is AVAH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AVAH. It does not provide personalized investment advice.

AVAH (Aveanna Healthcare Holdings Inc. Common Stock) Stock Analysis - Financials

Aveanna Healthcare Holdings Inc. Common Stock (AVAH) is a publicly traded Healthcare sector company. As of November 12, 2026, AVAH trades at $12.58 with a market cap of $2.88B and a P/E ratio of 11.03. AVAH moved -3.91% today. Year to date, AVAH is +59.34%; over the trailing twelve months it is +45.86%. Its 52-week range spans $3.73 to $14.71. Analyst consensus is buy with an average price target of $14.88. Rallies surfaces AVAH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are AVAH's key financials?

AVAH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AVAH recently traded at $12.58. Market cap is $2.88B. P/E ratio is 11.03. Revenue is $2.43B.

AVAH Key Metrics

Key financial metrics for AVAH
Metric	Value
Price	$12.58
Market Cap	$2.88B
P/E Ratio	11.03
EPS	$1.11
Dividend Yield	0.00%
52-Week High	$14.71
52-Week Low	$3.73
Volume	6.85K
Avg Volume	0
Revenue (TTM)	$2.43B
Net Income	$225.03M
Gross Margin	33.31%

AVAH Analyst Consensus

9 analysts cover AVAH: 0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.88.

Common questions about AVAH

What are AVAH's key financials?: AVAH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AVAH recently traded at $12.58. Market cap is $2.88B. P/E ratio is 11.03. Revenue is $2.43B.
Is AVAH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AVAH. It does not provide personalized investment advice.